FIELD: chemistry.SUBSTANCE: invention relates to pyridone amide compounds of formula I and I'where, independently for each case: G isor ；X is a bond or C1-C6 alkyl, wherein said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-； Rx is absent, is H or C3-C8 cycloaliphatic group, where up to two non-neighbouring CH2 units of the C3-C8 cycloaliphatic group can be substituted with -O- and said C3-C8 the cycloaliphatic group is substituted with 0-3 substituents selected from halogen and C1-C4 alkyl； R1 is H, halogen, CN or C1-C6 alkyl, where said C1-C6 alkyl is substituted with 0-6 halogen atoms and where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-； R2 is H, halogen, CN or C1-C6 alkyl, wherein said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-； R3 is H, halogen, CN or C1-C6 alkyl, wherein said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-； R4 is H, halogen, CN or C1-C6 alkyl, where said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-； R5 is H, halogen, CN or -X-Rx； R5’ is H, halogen, CN or -X-Rx； R6 is H, halogen, CN or -X-Rx； R6’ is H, halogen, CN or -X-Rx； R7 is H, halogen, CN or -X-Rx； R8 is a halogen or C1-C6 alkyl, where said C1-C6 alkyl is substituted with 0-6 halogen atoms, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-； p is an integer from 0 to 3, inclusively； and R9 is H or C1-C6 alkyl, where up to two non-neighbouring CH2 units of said C1-C6 alkyl can be substituted with -O-.EFFECT: invention relates to pharmaceutically acceptable salts used as inhibitors of sodium channels.48 cl, 4 tbl, 30 exИзобретение о
